168 related articles for article (PubMed ID: 2823422)
1. Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation.
Bowden RA; Day LM; Amos DE; Meyers JD
Transplantation; 1987 Oct; 44(4):504-8. PubMed ID: 2823422
[TBL] [Abstract][Full Text] [Related]
2. Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.
de Rham C; Hadaya K; Bandelier C; Ferrari-Lacraz S; Villard J
Transpl Immunol; 2014 Sep; 31(3):157-64. PubMed ID: 25158213
[TBL] [Abstract][Full Text] [Related]
3. Increased cytotoxicity against cytomegalovirus-infected target cells by bronchoalveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia.
Bowden RA; Dobbs S; Kopecky KJ; Crawford S; Meyers JD
J Infect Dis; 1988 Oct; 158(4):773-9. PubMed ID: 2844915
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
Gehrz RC; Rutzick SR
Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
[TBL] [Abstract][Full Text] [Related]
5. IL2 activated killer cells may contribute to cytomegalovirus induced marrow hypoplasia after bone marrow transplantation.
Duncombe AS; Grundy JE; Prentice HG; Brenner MK
Bone Marrow Transplant; 1991 Feb; 7(2):81-7. PubMed ID: 1646663
[TBL] [Abstract][Full Text] [Related]
6. NK recognition of cytomegalovirus-infected endothelial cells depends on viral replication and MHC class I expression.
Weinberg A; Zhang L; Tuder RM
Viral Immunol; 1996; 9(2):131-40. PubMed ID: 8822629
[TBL] [Abstract][Full Text] [Related]
7. Natural killing of cytomegalovirus-infected targets in renal transplant recipients.
Starr SE; Smiley L; Wlodaver C; Friedman HM; Plotkin SA; Barker C
Transplantation; 1984 Feb; 37(2):161-4. PubMed ID: 6320509
[TBL] [Abstract][Full Text] [Related]
8. HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections.
Quinnan GV; Burns WH; Kirmani N; Rook AH; Manischewitz J; Jackson L; Santos GW; Saral R
Rev Infect Dis; 1984; 6(2):156-63. PubMed ID: 6328614
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: the importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1).
Duncombe AS; Grundy JE; Oblakowski P; Prentice HG; Gottlieb DJ; Roy DM; Reittie JE; Bello-Fernandez C; Hoffbrand AV; Brenner MK
Blood; 1992 Jun; 79(11):3059-66. PubMed ID: 1316791
[TBL] [Abstract][Full Text] [Related]
10. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Jacobsen N; Andersen HK; Skinhøj P; Ryder LP; Platz P; Jerne D; Faber V
Scand J Haematol; 1986 May; 36(5):499-506. PubMed ID: 3016881
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
Lindsley MD; Torpey DJ; Rinaldo CR
J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881
[TBL] [Abstract][Full Text] [Related]
12. Alloreactive cytotoxic CD4+ responses elicited by cytomegalovirus-infected endothelial cells: role of MHC class I antigens.
Weinberg A; Zhang L; Hayward AR
Viral Immunol; 2000; 13(1):37-47. PubMed ID: 10733167
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
14. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.
Quinnan GV; Kirmani N; Rook AH; Manischewitz JF; Jackson L; Moreschi G; Santos GW; Saral R; Burns WH
N Engl J Med; 1982 Jul; 307(1):7-13. PubMed ID: 6281647
[TBL] [Abstract][Full Text] [Related]
17. [Immunity related to cytomegalovirus after allogenic bone marrow transplantation: role of donor immunity to cytomegalovirus in the incidence of cytomegalovirus infection in recipients].
Rabian-Herzog C; Varrin F; Gluckmann E; Bertrand C; Harzic M; Ferchal F
Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):331-6. PubMed ID: 6091224
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells and cytomegalovirus and Epstein-Barr virus infection in cardiac graft recipients.
Korcáková L; Kaslík J; Svobodová J; Nozicková M; Horák J; Kocandrle V; Fabián J; Raska I; Lejnar J; Franková V
Cor Vasa; 1988; 30(6):435-41. PubMed ID: 2853033
[TBL] [Abstract][Full Text] [Related]
20. The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection.
Quinnan GV; Rook AH
Birth Defects Orig Artic Ser; 1984; 20(1):245-61. PubMed ID: 6329365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
